Novartis Ag (NVSEF) Inventory Average (2009 - 2020)

Novartis Ag has disclosed Inventory Average across 6 years of filings, most recently posting $84.0 million for Q4 2020.

• Inventory Average for Q4 2020 came in at $84.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $84.0 million (changed N/A YoY), and the FY2025 annual result was $6.0 billion, up 3.06% from the prior year.
• Inventory Average came in at $84.0 million for Q4 2020 at Novartis Ag, roughly flat from $84.0 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $3.6 billion in Q3 2018 to a low of $6.0 million in Q2 2019.
• The 3-year median for Inventory Average is $111.8 million (2020), against an average of $1.4 billion.
• Peak annual rise in Inventory Average reached 1300.0% in 2020, while the deepest fall reached 95.99% in 2020.
• Novartis Ag's Inventory Average stood at $3.6 billion in 2018, then slumped by 99.83% to $6.0 million in 2019, then soared by 1300.0% to $84.0 million in 2020.
• The last three Inventory Average figures came in at $84.0 million (Q4 2020), $84.0 million (Q3 2020), and $84.0 million (Q2 2020), per Business Quant data.